AVADEL PHARMACEUTICALS PLC — Director's Dealing 2024

May 21, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2024-05-17

Reporting Person: Amin Naseem (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-17	Stock Option (Right to Buy)	$15.94	A	49500	Acquired	2034-05-17	Ordinary Shares (49500)	Direct

Footnotes

F1: The options become exercisable in three equal annual installments on each of the first three anniversaries following the 5/17/2024 grant date, subject to the Reporting Person's continued service at each such vesting date.